Phonak Lyric™, the 100% Invisible Hearing Aid, is Clinically Proven to Provide Relief of Tinnitus
STÄFA, SWITZERLAND / ACCESSWIRE / January 18, 2022 / Phonak, a leading global provider of life-changing hearing solutions, is excited to announce it recently joined the American Tinnitus Association’s (ATA) Corporate Engagement Program. Founded in 1971, ATA is the nation’s foremost organization committed to improving the lives of people with tinnitus by providing hope for a quieter future through education, advocacy, and research toward a cure. Phonak Lyric, the 100% invisible hearing aid that provides 24/7 hearing for weeks at a time, has been clinically proven to provide relief from tinnitus1, which affects approximately 26 million adults in the United States and is commonly referred to as “ringing in the ears.”
“Phonak is proud to support the American Tinnitus Association in their commitment to assist patients with tinnitus and help them find relief,” said Kelly Wassell, the Director of Marketing for Phonak Lyric. “This partnership underscores why hearing aids like Phonak Lyric are a viable treatment option for those with tinnitus. It also reinforces Phonak’s commitment to organizations that advance research, education, advocacy and awareness for the hearing health community.”
“Research shows that hearing aids can improve a patient’s quality of life by addressing hearing loss and utilizing masking functions that make tinnitus less intrusive,” said Torryn Brazell, chief executive officer of the ATA, referencing tinnitus practice guidelines released in 2014 by the American Academy of Otolaryngology-Head and Neck Surgery Foundation. “We’re proud to be able to partner with Phonak Lyric, a company that shares our vision of improving patients’ lives through improved technology, research, and working with healthcare professionals who understand the challenges of tinnitus,” Brazell said.
By partnering with the ATA, Phonak will support the non-profit’s initiatives that directly improve the lives of tinnitus patients, as well as the skills of their healthcare providers:
About the ATA
The core purpose of the American Tinnitus Association is to promote relief, prevent, and find cures for tinnitus, evidenced by its core values of compassion, credibility, and responsibility.
The leading cause of tinnitus is exposure to loud sound that damages an individual’s auditory system; the second leading cause is head or neck trauma. Tinnitus also is the leading service-connected disability for U.S. veterans. The ATA is almost exclusively funded by individual donors to fulfil its critical mission. Please donate and/or consider becoming a member so the ATA can continue to improve the quality of life for those living with tinnitus and to educate the public on its prevention. See http://www.ATA.org for more information.
If your tinnitus is causing you distress, getting help is crucial. Call the ATA at 1-800-634-8978, if you need general guidance on tinnitus management and seeking care.
About Phonak
Headquartered near Zurich, Switzerland, Phonak, a member of the Sonova Group, was created in 1947 out of a passion for taking on the most difficult hearing challenges. Seventy years later, this passion remains. As the industry’s leading innovator, we offer the broadest portfolio of life-changing hearing solutions. From pediatric to profound hearing loss, we remain committed to creating hearing solutions that change people’s lives to thrive socially and emotionally. We believe in creating a world where ‘Life is on’ for everyone.
At Phonak, we believe that hearing well is essential to living life to the fullest. For more than 70 years, we have remained true to our mission by developing pioneering hearing solutions that change people’s lives to thrive socially and emotionally. Life is on.
Media relations contacts:
Global
Florence Camenzind
Phone +41 58 928 33 25
Email florence.camenzind@sonova.com
U.S.
John Urbaniak
Phone +1 331 204 2799
Email john.urbaniak@sonova.com
Source/References
1 Henry, J.A., McMillan, G., Dann, S., Bennett, K., Griest, S., Theodoroff, S., Silverman, SP., Whichard, S., & Saunders, G. (2017).Tinnitus Management: Randomized Controlled Trial Comparing Extended-Wear Hearing Aids, Conventional Hearing Aids, and Combination Instruments. Journal of the American Academy of Audiology. 28(6): 546-561.https://doi.org/10.3766/jaaa.16067
SOURCE: Phonak
View source version on accesswire.com:
https://www.accesswire.com/683820/Phonak-Becomes-a-Patron-Partner-of-the-American-Tinnitus-Association
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…